Advisor Group, Inc. - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 13 filers reported holding CLEVELAND BIOLABS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2019$0250.0%0.00%
Q3 2019$0250.0%0.00%
Q2 2019$0250.0%0.00%
Q1 2019$0250.0%0.00%
Q4 2018$0250.0%0.00%
Q3 2018$0250.0%0.00%
Q2 2018$0250.0%0.00%
Q1 2018$0250.0%0.00%
Q4 2017$025
-32.4%
0.00%
Q3 2017$0370.0%0.00%
Q2 2017$0370.0%0.00%
Q1 2017$0370.0%0.00%
Q4 2016$0370.0%0.00%
Q3 2016$0370.0%0.00%
Q2 2016$0370.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q2 2019
NameSharesValueWeighting ↓
LADENBURG THALMANN FINANCIAL SERVICES INC. 38,888$163,0000.00%
Virtu KCG Holdings LLC 21,002$73,0000.00%
Winfield Associates, Inc. 500$2,0000.00%
VANGUARD GROUP INC 87,518$306,0000.00%
UBS Group AG 1,423$5,0000.00%
BLACKROCK ADVISORS LLC 2,800$10,0000.00%
IFP Advisors, Inc 775$3,0000.00%
US BANCORP \DE\ 100$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 37$00.00%
BANK OF AMERICA CORP /DE/ 125$00.00%
View complete list of CLEVELAND BIOLABS INC shareholders